Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs

Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating... Arch Gynecol Obstet (2017) 296:543–549 DOI 10.1007/s00404-017-4444-3 GY NEC O LOG I C O NCO L OG Y Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs 1,2 3 2 2 2 • • • • • Shujian Xu Cui Zhao Zhongming Jia Xilong Wang Yong Han Zhenlin Yang Received: 2 January 2017 / Accepted: 22 June 2017 / Published online: 28 June 2017 Springer-Verlag GmbH Germany 2017 Abstract Conclusion MiR-891b increases the sensitivity of the Purpose Breast cancer is the most common invasive type breast cancer cells (HCC1806) to the cytotoxic effects of of cancer among women. Role of different microRNAs the chemotherapeutic agent MNNG by suppressing the (miRNAs) and poly(ADP-ribose) polymerases (PARPs) in expression of PARP1. breast cancer has been well established. This study aimed to explore the effects of miR-891b on sensitizing breast Keywords Breast cancer  MicroRNA-181b  PARP1 cancer cells to alkylating chemotherapeutic drugs through Alkylating chemotherapeutic agent  MNNG PARPs. Methods The expression of miR-891b and PARP1 in human breast cancer cells HCC1806 was overexpressed by Introduction transfection with their mimics or expressing vector. Then, the transfected cells were exposed to 40 lM N-methyl-N- Breast cancer is considered http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Gynecology and Obstetrics Springer Journals

Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs

Loading next page...
 
/lp/springer_journal/down-regulation-of-parp1-by-mir-891b-sensitizes-human-breast-cancer-l6USXd1ZPF
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Gynecology; Obstetrics/Perinatology/Midwifery; Endocrinology; Human Genetics
ISSN
0932-0067
eISSN
1432-0711
D.O.I.
10.1007/s00404-017-4444-3
Publisher site
See Article on Publisher Site

Abstract

Arch Gynecol Obstet (2017) 296:543–549 DOI 10.1007/s00404-017-4444-3 GY NEC O LOG I C O NCO L OG Y Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs 1,2 3 2 2 2 • • • • • Shujian Xu Cui Zhao Zhongming Jia Xilong Wang Yong Han Zhenlin Yang Received: 2 January 2017 / Accepted: 22 June 2017 / Published online: 28 June 2017 Springer-Verlag GmbH Germany 2017 Abstract Conclusion MiR-891b increases the sensitivity of the Purpose Breast cancer is the most common invasive type breast cancer cells (HCC1806) to the cytotoxic effects of of cancer among women. Role of different microRNAs the chemotherapeutic agent MNNG by suppressing the (miRNAs) and poly(ADP-ribose) polymerases (PARPs) in expression of PARP1. breast cancer has been well established. This study aimed to explore the effects of miR-891b on sensitizing breast Keywords Breast cancer  MicroRNA-181b  PARP1 cancer cells to alkylating chemotherapeutic drugs through Alkylating chemotherapeutic agent  MNNG PARPs. Methods The expression of miR-891b and PARP1 in human breast cancer cells HCC1806 was overexpressed by Introduction transfection with their mimics or expressing vector. Then, the transfected cells were exposed to 40 lM N-methyl-N- Breast cancer is considered

Journal

Archives of Gynecology and ObstetricsSpringer Journals

Published: Jun 28, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off